These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 18806702

  • 1. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M.
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [Abstract] [Full Text] [Related]

  • 2. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 3. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM, Flourie B.
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [Abstract] [Full Text] [Related]

  • 4. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of probiotics in IBS.
    Quigley EM.
    J Clin Gastroenterol; 2008 Jul 15; 42 Suppl 2():S85-90. PubMed ID: 18542036
    [Abstract] [Full Text] [Related]

  • 6. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM.
    Curr Opin Pharmacol; 2008 Dec 15; 8(6):704-8. PubMed ID: 18775516
    [Abstract] [Full Text] [Related]

  • 7. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y, Ringel-Kulka T.
    J Clin Gastroenterol; 2011 Nov 15; 45 Suppl():S145-8. PubMed ID: 21992954
    [Abstract] [Full Text] [Related]

  • 8. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct 15; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 9. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 15; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 10. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
    Brenner DM, Chey WD.
    Rev Gastroenterol Disord; 2009 Mar 15; 9(1):7-15. PubMed ID: 19367213
    [Abstract] [Full Text] [Related]

  • 11. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R, Savarese MF, Gargano R.
    Dig Dis; 2007 Mar 15; 25(3):241-4. PubMed ID: 17827948
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):994-1002. PubMed ID: 18671775
    [Abstract] [Full Text] [Related]

  • 13. Is there a role for probiotics in irritable bowel syndrome?
    Camilleri M.
    Dig Liver Dis; 2006 Dec 15; 38 Suppl 2():S266-9. PubMed ID: 17259088
    [Abstract] [Full Text] [Related]

  • 14. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM.
    J Dig Dis; 2007 Feb 15; 8(1):2-7. PubMed ID: 17261128
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC, Brostoff J, Whelan K, Sanderson JD.
    Am J Gastroenterol; 2008 Jun 15; 103(6):1557-67. PubMed ID: 18513268
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study.
    Andriulli A, Neri M, Loguercio C, Terreni N, Merla A, Cardarella MP, Federico A, Chilovi F, Milandri GL, De Bona M, Cavenati S, Gullini S, Abbiati R, Garbagna N, Cerutti R, Grossi E.
    J Clin Gastroenterol; 2008 Sep 15; 42 Suppl 3 Pt 2():S218-23. PubMed ID: 18685503
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.